
News|Articles|May 1, 2002
Ezetimibe added to a statin results in greater LDL reduction
Adding the investigational cholesterol absorption inhibitor ezetimibe to statin therapy results in additional reductions in low-density lipoprotein (LDL) cholesterol of up to 14%.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Arpit Patel. Pharm.D., MedImpact
2
Investigational non-opioid LTG-001 reduced acute pain in phase 2b trial
3
Mitchell Warren says 3M lenacapavir goal falls short | AIDS 2026
4
CMS Medicaid Fraud War Room stops more than $203 million in improper payments
5




















